SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,547,000 | +107.1% | 13,996 | +40.5% | 0.05% | +92.9% |
| Q2 2022 | $747,000 | +55.3% | 9,962 | +61.9% | 0.03% | +75.0% |
| Q1 2022 | $481,000 | +40.6% | 6,154 | +62.2% | 0.02% | +33.3% |
| Q4 2021 | $342,000 | -50.7% | 3,795 | -49.4% | 0.01% | -47.8% |
| Q3 2021 | $694,000 | -72.1% | 7,503 | -57.6% | 0.02% | -91.3% |
| Q3 2020 | $2,485,000 | +495.9% | 17,696 | +580.1% | 0.26% | +473.9% |
| Q2 2020 | $417,000 | +134.3% | 2,602 | +10.1% | 0.05% | -9.8% |
| Q3 2019 | $178,000 | +17700.0% | 2,363 | +26155.6% | 0.05% | – |
| Q4 2018 | $1,000 | -66.7% | 9 | -88.5% | 0.00% | -100.0% |
| Q2 2017 | $3,000 | – | 78 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |